CheckMyRecalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Diclofenac Sodium

Published
11 Feb 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot # AD92721, Exp Date: 3/31/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.